Koninklijke Philips (PHIA) Q4 2025 earnings summary

Executive summary

• Delivered strong Q4 and full-year 2025 results, fully meeting outlook with consistent execution, robust order intake up 7% in Q4 and 6% for the year, and strong momentum for 2026.

• Achieved sales growth, margin expansion, and strong free cash flow despite a dynamic macro environment, with North America leading growth.

• Innovation, productivity, and disciplined execution drove margin expansion and cash generation.

• Net income and income from operations rose significantly, supporting a solid foundation for accelerated growth and profitability in 2026.

• Strong exit momentum and strategic partnerships set up for further growth.

Financial highlights

• Q4 2025 sales reached €5,097 million, up from €5,044 million in Q4 2024; full-year sales were €17,834 million, with 7% Q4 and 2%-2.3% full-year comparable sales growth.

• Adjusted EBITA/EBITDA margin improved by 160 bps to 15.1% in Q4 and by 80 bps to 12.3% for the year.

• Net income for 2025 was EUR 897 million, with Q4 net income at EUR 397 million; adjusted EPS up 20% YoY.

• Free cash flow was EUR 1.2 billion in Q4 and EUR 512 million for the year, despite over EUR 1 billion in settlement payments.

• Leverage ratio improved to 1.7x net debt/adjusted EBITDA; net debt position at €5.3 billion.

Outlook and guidance

• 2026 guidance: comparable sales growth of 3%-4.5%, adjusted EBITA/EBITDA margin of 12.5%-13.0%, and free cash flow of EUR 1.3-1.5 billion.

• Tariff costs fully annualized in 2026, with net impact of EUR 250-300 million after mitigations.

• Adjusting items expected to decline to 200 bps in 2026.

• Net debt/Adjusted EBITDA targeted at 1.6–1.8x, maintaining investment-grade credit rating.

• Mid-term (2026-2028) targets: mid-single-digit comparable sales CAGR, mid-teens Adjusted EBITA margin by 2028, and cumulative free cash flow of EUR 4.5-5.0 billion.